The key questions and considerations for drug manufacturers pursuing an effective alternative distribution model.
Rob Besse, Archbow Consulting
Advertisement
Rob Besse is a Vice President and Subject Matter Expert in
Distribution at Archbow Consulting.
Articles by Rob Besse, Archbow Consulting
Advertisement
Latest Updated Articles
Are ADMs a Viable Option for Pharma?Published: August 4th 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models
2
Cambrex Commits $120 Million to Grow US API Manufacturing
3
How Biopharma Companies Can Optimize Field Reimbursement Models
4
Direct-to-patient: pharma’s next power move
5
